Rahul Jandial, M.D., Ph.D.: Pediatric Neurosurgery Humanitarian Missions

March 13, 2018 | Denise Heady

Fourteen years ago, neurosurgeon and scientist Rahul Jandial, M.D., Ph.D., began to travel to underserved countries to perform brain surgeries on disadvantaged children.

Continue Reading

City of Hope Researchers Find “Achilles' Heel” in B Cell Tumors

March 14, 2018 | Katie Neith

In a new paper published in the journal Cell, a team of researchers led by City of Hope’s Markus Müschen, M.D., Ph.D., and Gang Xiao, Ph.D., reports on the discovery of a new therapeutic target for these B cell malignancies.

‘Goldilocks’ Therapies Could Be a Breakthrough for Patients with Lymphoma

March 6, 2018 | City of Hope

Thanks to research being done by City of Hope's Markus Müschen, M.D., Ph.D., lymphoma patients may soon receive treatments that leverage quality control mechanisms that our own immune systems utilize to fight harmful antibodies.

New Researcher Takes Aim at Acute Myeloid Leukemia

February 27, 2018 | City of Hope

Acute myeloid leukemia, or AML, is one of the most common and fatal forms of blood-related cancers. Jianjun Chen, Ph.D., a new faculty member at City of Hope, dedicates much of his research program to learning more about the disease.

Researchers discover sugar-addiction of cancer cells in childhood leukemia

July 10, 2017 | Katie Neith

According to a new article in Nature, a team led by City of Hope’s Markus Müschen, M.D., Ph.D., Chair of the Department of Systems Biology, thinks that sugar uptake and energy supply may play a key role in the relapse of ALL.

The Search for the Elephant Gene

July 5, 2017 | Michael Easterling

The African bull elephant is the largest mammal on the planet, comprised of trillions of cells that should ostensibly be a breeding ground for cancer. But because of an evolutionary anomaly, elephants don’t get cancer, a fact that fascinates Markus Müschen, M.D., Ph.D.

Markus Müschen, M.D., Ph.D., Is a Man on a Mission: Ending Childhood Leukemia

February 14, 2017 | Abe Rosenberg

Hailed as one of the best researchers of his generation, Markus Müschen, M.D., Ph.D., has joined City of Hope with the singular goal of wiping out Acute Lymphoblastic Leukemia (ALL), the most common form of cancer in children.